Mefloquine the drug's very long half-life, the Centers for Disease Control originally recommended a mefloquine dosage of 250 mg every two weeks; however, this caused an unacceptably high malaria rate in the Peace Corps volunteers who participated in the approval study, so the drug regimen was switched to once a week. The first randomized, controlled trial on a mixed population was performed in 2001. Prophylaxis with mefloquine was compared to prophylaxis with atovaquone-proguanil. Roughly 67% of participants in the mefloquine arm reported greater than or equal to one adverse event, vs 71% in the atovaquone-proguanil arm. In the mefloquine arm, 5%
Hyperbaric treatment schedules has shown success over the years. IWR is not without risk and should be undertaken with certain precautions. IWR would only be suitable for an organised and disciplined group of divers with suitable equipment and practical training in the procedure. Treatment of decompression sickness, arterial gas embolism, and other medical applications. The type of chamber which can be used depends on the maximum pressure required for the schedule, and what gases are used for treatment. Most treatment protocols for diving injuries require an attendant in the chamber, and a medical lock to transfer medical supplies into the chamber while under